Minnesota Medicaid Coverage for Wegovy Minnesota Medicaid, administered through Medical Assistance (MA), covers Wegovy with prior authorization
Cagrilintide is an amylin analog that complements semaglutide's GLP-1 mechanism by slowing gastric emptying, reducing appetite through different brain pathways, and enhancing satiety
If a screening protocol has not been developed or implemented within your institution, then use the full AUDIT tool or ask patients if they would like medications to help reduce cravings Offer medications for AUD : For patients who screen positive for AUD or express interest in reducing alcohol intake, discuss evidence-based options such as naltrexone
However, when combined with sulphonylureas or insulin, the risk increases significantly, and doses of these medications may need reduction under clinical supervision to prevent low blood glucose and associated dizziness
It is important for patients to follow their healthcare professional's advice very closely
Unless developers adjust how they think about risk, subtle but serious issues may slip past traditional GLP safety playbooks